ArticleBMC cancer2021

Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma.

Bo Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.